Main Article Content
Objective: Obesity is one of the crucial risk factor for cardiometabolic syndrome in general population as well as in schizophrenicpatients. Zonisamide was known for its weight reducing effect in the treatment of epileptic patients and some bipolar patients.The aim of this study was to investigate the weight reducing effect of zonisamide in combination with weight managementprogram designed for schizophrenic inpatients.
Method: One hundred twenty obese schizophrenic inpatients (BMI>27) were randomly assigned to 4 groups: A, controlgroup (N=19), B, zonisamide alone group (N=34), C, weight reduction program alone group (N=32), and D, combination ofzonisamide and weight reduction group (N=35). Daily dose of zonisamide was 100mg/day. Weight-related variables, laboratorytests and side effects were assessed by monthly intervals for 3 months.
Results: Dropouts were 41 patients during 3 months of trial (group A=7 (41.2%), group B=10 (29.4%), group C=17 (53.1%) andgroup D=7 (20%)). Weight loss was significant in group B, C, D from baseline after 2 month of trial. BMI was also significantlydecreased in group B, C and D. Waist circumferences were significantly decreased in group C and D. Blood pressure and bloodglucose was not changed after 3 months of trial. Blood triglyceride was significantly decreased in group B, C and D. HDLcholesterolwas significantly increased in group B and D. Rash was occurred in 3 patients of zonisamide trial groups (4.3%).Other serious adverse events were not found.
Conclusion: Although the combination of zonisamide and weight reduction program was not superior to drug alone or weightreduction treatment alone, our result showed that zonisamide seems to be safe and effective for weight reducing in obeseschizophrenic inpatients.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).